Literature DB >> 11776380

Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation.

J Podolski1, T Byrski, S Zajaczek, T Druck, D B Zimonjic, N C Popescu, G Kata, A Borowka, J Gronwald, J Lubinski, K Huebner.   

Abstract

A Polish family was identified in which multifocal clear cell renal carcinoma segregated with a balanced constitutional chromosome translocation, t(2:3)(q33;q21), similar to the renal cell cancer-associated t(2;3)(q35;q21) reported in a Dutch family. Bacterial artificial chromosome (BAC) contigs encompassing the 2q and 3q breakpoints were constructed and BACs crossing the breakpoints were partially sequenced. All known regional markers, genes, and expressed sequence tags (ESTs) were mapped relative to the contigs, as well as to the breakpoint sequences. Two single ESTs mapped within the 2q breakpoint BAC, whereas the repeat-rich 3q breakpoint region was gene poor. Physical mapping suggested that the 3q break was in 3q13, possibly near the border with 3q21. Physical mapping illustrated that the 2q break was closely telomeric to the 2q31 FRA2G site, consistent with the G-band assignment. Characterization of full-length cDNAs for the ESTs near the 2q break will determine if a gene(s) is altered by this familial translocation.

Entities:  

Mesh:

Year:  2001        PMID: 11776380     DOI: 10.1007/s100380170001

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  6 in total

1.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  PTPRF is disrupted in a patient with syndromic amastia.

Authors:  Surasawadee Ausavarat; Siraprapa Tongkobpetch; Verayuth Praphanphoj; Charan Mahatumarat; Nond Rojvachiranonda; Thiti Snabboon; Thomas C Markello; William A Gahl; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  BMC Med Genet       Date:  2011-03-31       Impact factor: 2.103

Review 3.  Hereditary kidney cancer: unique opportunity for disease-based therapy.

Authors:  W Marston Linehan; Peter A Pinto; Gennady Bratslavsky; Elizabeth Pfaffenroth; Maria Merino; Cathy D Vocke; Jorge R Toro; Donald Bottaro; Len Neckers; Laura S Schmidt; Ramaprasad Srinivasan
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

4.  Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics.

Authors:  W Marston Linehan
Journal:  Genome Res       Date:  2012-10-04       Impact factor: 9.043

5.  Epidemiology of kidney cancer.

Authors:  D Pascual; A Borque
Journal:  Adv Urol       Date:  2008-11-04

Review 6.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.